🇺🇸 FDA
Patent

US 10583173

Methods of treating or preventing pruritis by blocking natriuretic polypeptide b

granted A61KA61K38/164A61K38/1796

Quick answer

US patent 10583173 (Methods of treating or preventing pruritis by blocking natriuretic polypeptide b) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/164, A61K38/1796, A61K38/22, A61K38/2242